Abata Therapeutics Company

Abata Therapeutics is a biotech company focused on translating the biology of regulatory T cells (Tregs) into transformational medicine.

Founded Date: 1/1/2021
Total Funding: 95000000
Employee Number: 51-100
Funding Status: Early Stage Venture
Last Funding Type: Series A
Industry: PharmTech
Headquarters: Cambridge, Massachusetts, United States